PharVision Advisers »

Ensign shares owned by PharVision Advisers

Quarter-by-quarter ownership of Ensign (ENSG) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Ensign

Tip: Access up to 7 years of quarterly data

All positions including Ensign held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ensign by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-03-31 $407k 3.1k 129.40
2024-12-31 $490k 3.7k 132.86

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Ensign

BlackRock
Vanguard Group
Baillie Gifford & Co
Daniel D. Thurber
FMR
State Street Corporation
Capital Research Global Investors
Geode Capital Management
Hanna Zanoni
Dimensional Fund Advisors
Northern Trust
Wellington Management Company
Charles Schwab Investment Management
Van Berkom & Associates
Riverbrige Partners

View all funds holding Ensign